Search results (347)
« Back to NewsDeputy Directors of the MRC Weatherall Institute of Molecular Medicine
7 May 2026
Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.
Congratulations to our new Associate Professors
7 May 2026
RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.
Naveed Akbar awarded International Cardiovascular Research Partnership funding
7 May 2026
Leading mid-career scientists from the UK, France, Germany, and the Netherlands have received almost €6 million from a pioneering partnership between the British Heart Foundation (BHF), the Dutch Heart Foundation (DHF), the German Centre for Cardiovascular Research (DZHK) and the Lefoulon Delalande Foundation (LDF), to support vital international research collaborations work over four years.
Research uncovers new mechanism controlling inflammation in immune cells
29 April 2026
Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
Kevin Rue-Albrecht to lead BioFAIR Pathfinder Project
22 April 2026
Congratulations to Dr Kevin Rue-Albrecht, who has been selected as one of BioFAIR’s inaugural Pathfinder Projects.
Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme
15 April 2026
Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.
New AI tool can predict heart failure at least five years before it develops
8 April 2026
Programme uses data from routine CT scans to help doctors identify high-risk patients earlier than ever before
Onima Chowdhury receives Cancer Research UK clinical trial grant
8 April 2026
Congratulations to Dr Onima Chowdhury, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.
Announcing new Principal Investigator 2026
7 April 2026
Following RDM’s annual call for researchers to apply for Principal Investigator (PI) status, we are delighted to announce the designation of a new PIs for 2026.
Verena Korber receives CRUK Career Development Fellowship
1 April 2026
Congratulations to Dr Verena Korber, who has been awarded a Career Development Fellowship from Cancer Research UK.
Heavier drinking linked to higher levels of harmful “hidden” fat, study finds
25 March 2026
A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.
Paul Leeson named NIHR Senior Investigator
24 March 2026
Professor Paul Leeson is one of seven academics in the University of Oxford's Medical Sciences Division who have been named National Institute of Health Research (NIHR) Senior Investigators. This award recognises the most prominent and prestigious researchers of applied health and social care.
DNA-damaging formaldehyde accelerates blood ageing by extinction of stem cells
23 March 2026
Researchers from the University of Oxford, the German Cancer Research Center, and Hospital Saint-Louis have uncovered a surprising new way that blood stem cells are lost over time, offering fresh insight into ageing and diseases that affect blood production.
Hal Drakesmith and Jon Wade awarded UKRI funding to understand how metals regulate biology
23 March 2026
Congratulations to Hal Drakesmith and Jon Wade, who have received a grant from UKRI to investigate how metals influence metabolism, disease, and ecosystem stability, marking a new interdisciplinary approach to advancing metal biology.
Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
23 March 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.
Study identifies immune–metabolic pathway as potential target in diabetic heart disease
19 March 2026
Researchers have shown that a drug originally developed to lower blood sugar can improve heart function and reduce inflammation in a preclinical model of type 2 diabetes.
RDM Day 2026: Celebrating scientific excellence and collaboration
18 March 2026
RDM Day, held on Tuesday 17 March at the Mathematical Institute, brought together researchers, professional services staff and students from across the Radcliffe Department of Medicine for a full day of science, networking and community building.
New study reveals how blood cell production responds to parasite infection
11 March 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.